{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:19:03Z","timestamp":1789730343242,"version":"4.0.1"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bmc.2026.118586","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:06:24Z","timestamp":1770739584000},"page":"118586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["From pain relief to proliferation arrest: Synthesis and biological evaluation of novel diclofenac-tethered Schiff bases as VEGFR-2 inhibitors and apoptosis inducers, guided by in silico molecular docking and ADME profiling"],"prefix":"10.1016","volume":"136","author":[{"given":"Nadia A.","family":"Khalil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Halim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Magdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8472-9880","authenticated-orcid":false,"given":"Eman O.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118586_bb0005","first-page":"128","article-title":"Comparative study of Cancer profiles between 2020 and 2022 using global Cancer statistics (GLOBOCAN)","volume":"4","author":"Cao","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"10.1016\/j.bmc.2026.118586_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20503121211034366","article-title":"New approaches and procedures for Cancer treatment: current perspectives","volume":"9","author":"Debela","year":"2021","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.bmc.2026.118586_bb0015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2026.118586_bb0020","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.3390\/cancers3033279","article-title":"Assessment of the evolution of Cancer treatment therapies","volume":"3","author":"Arruebo","year":"2011","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bmc.2026.118586_bb0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fphar.2018.00245","article-title":"Editorial: adverse effects of Cancer chemotherapy: anything new to improve tolerance and reduce sequelae","volume":"9","author":"Nurgali","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2026.118586_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122390","article-title":"Chronic inflammation and cancer; the two sides of a coin","volume":"338","author":"Fernandes","year":"2024","journal-title":"Life Sci"},{"key":"10.1016\/j.bmc.2026.118586_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2025.100347","article-title":"Unveiling the link between chronic inflammation and Cancer","volume":"25","author":"Tripathi","year":"2025","journal-title":"Metabol Open"},{"key":"10.1016\/j.bmc.2026.118586_bb0040","first-page":"00053","article-title":"Chronic inflammation following hernia repair and Cancer risk: a Nationwide study","volume":"6","author":"Broholm","year":"2025","journal-title":"Surg Open Sci"},{"key":"10.1016\/j.bmc.2026.118586_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108962","article-title":"Indole-imidazolone derivatives as dual Mcl-1\/COX-2 inhibitors: design-oriented synthesis, molecular docking, and dynamics studies with potential anticancer and anti-inflammatory activities","volume":"165","author":"Lamie","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0050","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","article-title":"Nonresolving inflammation","volume":"140","author":"Nathan","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2026.118586_bb0055","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh Hallmark of Cancer: links to genetic instability","volume":"30","author":"Colotta","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bmc.2026.118586_bb0060","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fnagi.2016.00126","article-title":"Chronic inflammation links Cancer and Parkinson\u2019s disease","volume":"8","author":"Li","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.bmc.2026.118586_bb0065","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1084\/jem.20181739","article-title":"Modulating inflammation for Cancer therapy","volume":"216","author":"Ritter","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.bmc.2026.118586_bb0070","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/onc.2009.441","article-title":"Defining the role of hypoxia-inducible factor 1 in Cancer biology and therapeutics","volume":"29","author":"Semenza","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.bmc.2026.118586_bb0075","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.3390\/ijms22115421","article-title":"Inflammation-induced tumorigenesis and metastasis","volume":"22","author":"Hibino","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118586_bb0080","first-page":"758","article-title":"Hypoxia-inducible factors: master regulators of Cancer progression, trends","volume":"2","author":"Schito","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.bmc.2026.118586_bb0085","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.RES.0000259593.07661.1e","article-title":"Endothelial cell migration during angiogenesis","volume":"100","author":"Lamalice","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.bmc.2026.118586_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr2482","article-title":"Prescriptions for selective Cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast Cancer in a population-based case-control study","volume":"12","author":"Cronin-Fenton","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.bmc.2026.118586_bb0095","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","article-title":"Aspirin and non-steroidal anti-inflammatory drugs for Cancer prevention: an international consensus statement","volume":"10","author":"Cuzick","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bmc.2026.118586_bb0100","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3892\/ijo.2011.1304","article-title":"Aspirin induces apoptosis in vitro and inhibits tumor growth of human hepatocellular carcinoma cells in a nude mouse xenograft model","volume":"40","author":"Hossain","year":"2012","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bmc.2026.118586_bb0105","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000452315","article-title":"The role of NSAIDs in breast Cancer prevention and relapse: current evidence and future perspectives","volume":"11","author":"Moris","year":"2016","journal-title":"Breast Care"},{"key":"10.1016\/j.bmc.2026.118586_bb0110","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1185\/03007995.2010.486301","article-title":"Diclofenac: an update on its mechanism of action and safety profile","volume":"26","author":"Gan","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.bmc.2026.118586_bb0115","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3892\/etm.2021.10016","article-title":"Diclofenac impairs the proliferation and glucose metabolism of triple-negative breast Cancer cells by targeting the c-Myc pathway","volume":"21","author":"Yang","year":"2021","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.bmc.2026.118586_bb0120","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1080\/13102818.2021.1953401","article-title":"Cytotoxic and antiproliferative effects of the nonsteroidal anti-inflammatory drug diclofenac in human tumour cell lines","volume":"35","author":"Marinov","year":"2021","journal-title":"Biotechnol Biotechnol Equip"},{"key":"10.1016\/j.bmc.2026.118586_bb0125","doi-asserted-by":"crossref","first-page":"7210","DOI":"10.1158\/0008-5472.CAN-04-1795","article-title":"Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo","volume":"64","author":"Johnsen","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2026.118586_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061836","article-title":"Non-steroidal anti-inflammatory drugs decrease E2F1 expression and inhibit cell growth in ovarian Cancer cells","volume":"8","author":"Valle","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2026.118586_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140613","article-title":"Ibuprofen and diclofenac restrict migration and proliferation of human glioma cells by distinct molecular mechanisms","volume":"10","author":"Leidgens","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2026.118586_bb0140","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.freeradbiomed.2004.07.003","article-title":"Molecular mechanism of diclofenac-induced apoptosis of promyelocytic Leukemia: dependency on reactive oxygen species, Akt, bid, cytochrome c, and caspase pathway","volume":"37","author":"Inoue","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bmc.2026.118586_bb0145","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.biochi.2012.12.012","article-title":"Markers of mitochondrial dysfunction during the diclofenac-induced apoptosis in melanoma cell lines","volume":"95","author":"Albano","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.bmc.2026.118586_bb0150","first-page":"610","article-title":"Repurposing drugs in oncology (ReDO) - diclofenac as an anti-Cancer agent","volume":"10","author":"Pantziarka","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.bmc.2026.118586_bb0155","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/14756366.2018.1474878","article-title":"Synthesis, antitumour activities and molecular docking of thiocarboxylic acid Ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studies","volume":"33","author":"El-Azab","year":"2018","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0160","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.3390\/ijms22105067","article-title":"Diclofenac N-derivatives as therapeutic agents with anti-inflammatory and anti-Cancer effect","volume":"22","author":"Galisteo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118586_bb0165","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1080\/10426507.2020.1759060","article-title":"Synthesis and biological activity evaluation of new Thiazolidinone-diclofenac hybrid molecules","volume":"195","author":"Shepeta","year":"2020","journal-title":"Phosphorus Sulfur Silicon Relat Elem"},{"key":"10.1016\/j.bmc.2026.118586_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.6060\/ivkkt.20246712.7071","article-title":"New biaryl derivatives of diclofenac drug: synthesis, molecular docking and their biological activity study as anticancer and antioxidant agents","volume":"67","author":"Abdul-Rida","year":"2024","journal-title":"ChemChemTech"},{"key":"10.1016\/j.bmc.2026.118586_bb0175","article-title":"Advances in diclofenac derivatives: exploring Carborane-substituted N-methyl and nitrile Analogs for anticancer therapy","volume":"20","author":"Selg","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2026.118586_bb0180","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3390\/pharmaceutics16060826","article-title":"Unveiling anticancer potential of COX-2 and 5-LOX inhibitors: cytotoxicity, Radiosensitization potential and antimigratory activity against colorectal and pancreatic carcinoma","volume":"16","author":"Bo\u0161kovi\u0107","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bmc.2026.118586_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.142863","article-title":"Design, synthesis, in silico and in vitro studies urea derivatives as VEGFR-2 inhibitors","volume":"1343","author":"Chfat","year":"2025","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2026.118586_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2023.107953","article-title":"Design, semi-synthesis, anti-cancer assessment, docking, MD simulation, and DFT studies of novel theobromine-based derivatives as VEGFR-2 inhibitors and apoptosis inducers","volume":"107","author":"Eissa","year":"2023","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0195","doi-asserted-by":"crossref","first-page":"14477","DOI":"10.1039\/D5RA01223F","article-title":"New nicotinamide-thiadiazol hybrids as VEGFR-2 inhibitors for breast Cancer therapy: design, synthesis and in silico and in vitro evaluation","volume":"15","author":"Elgammal","year":"2025","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2026.118586_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107829","article-title":"Design, synthesis, and in silico insights of novel N\u2019-(2-Oxoindolin-3-ylidene)piperidine-4-carbohydrazide derivatives as VEGFR-2 inhibitors","volume":"153","author":"Eldehna","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900340","article-title":"Design, synthesis, and molecular docking of novel 2-Arylbenzothiazole multiangiokinase inhibitors targeting breast Cancer","volume":"353","author":"Abdel-Mohsen","year":"2020","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmc.2026.118586_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109075","article-title":"Design, synthesis and biological evaluation of novel pyrazoline derivatives as dual EGFR\/VEGFR-2 inhibitors for targeted Cancer therapy","volume":"165","author":"Sawiris","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137465","article-title":"New modified Thieno[2,3-d] pyrimidine derivatives as VEGFR-2 inhibitors: design, synthesis, in vitro anti-cancer evaluation and divers in silico studies","volume":"1302","author":"El-Metwally","year":"2024","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2026.118586_bb0220","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/1535-7163.MCT-11-0264","article-title":"Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth","volume":"10","author":"Yakes","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bmc.2026.118586_bb0225","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/ph15111416","article-title":"Design, synthesis, molecular Modeling, and anticancer evaluation of new VEGFR-2 inhibitors based on the Indolin-2-one scaffold","volume":"15","author":"Abdelgawad","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmc.2026.118586_bb0230","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.bmcl.2015.03.088","article-title":"Design, synthesis and biological evaluation of deuterated tivozanib for improving pharmacokinetic properties","volume":"25","author":"Guo","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118586_bb0235","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejmech.2016.02.029","article-title":"Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: design, synthesis and biological evaluation of 1-Substituted-4-(4-methoxybenzyl)phthalazine derivatives","volume":"113","author":"Eldehna","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0240","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1002\/slct.202102619","article-title":"An insight into the biological properties of imidazole-based Schiff bases: a review","volume":"6","author":"Gopalakrishnan","year":"2021","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmc.2026.118586_bb0245","first-page":"1","article-title":"Synthesis, anti-inflammatory activity, and in silico study of novel diclofenac and Isatin conjugates","volume":"2018","author":"Ibrahim","year":"2018","journal-title":"Int J Med Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0250","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.bmc.2014.03.043","article-title":"Synthesis, pharmacological screening and in silico studies of new class of diclofenac analogues as a promising anti-inflammatory agents","volume":"22","author":"Palkar","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0255","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3390\/microorganisms13071563","article-title":"Design, synthesis, and biological evaluation of N-Acylhydrazones and their activity against leishmania Amazonensis promastigotes","volume":"13","author":"Oliveira Monteiro","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.bmc.2026.118586_bb0260","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.3390\/molecules26164908","article-title":"Synthesis of novel N-Acylhydrazones and their C-N\/N-N bond conformational characterization by Nmr spectroscopy","volume":"26","author":"Munir","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2026.118586_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107101","article-title":"Development of new Thieno[2,3-d] pyrimidines as dual EGFR and STAT3 inhibitors endowed with anticancer and pro-apoptotic activities","volume":"143","author":"Elsebaie","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106444","article-title":"Design, synthesis, cytotoxic activities, and molecular docking of chalcone hybrids bearing 8-hydroxyquinoline moiety with dual tubulin\/EGFR kinase inhibition","volume":"134","author":"Amin","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115304","article-title":"Molecular design, synthesis and anticancer activity of new Thiopyrano[2,3-d]thiazoles based on 5-Hydroxy-1,4-naphthoquinone","volume":"252","author":"Ivasechko","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106434","article-title":"Design and synthesis of novel N-terminal peptides of integrin and aminopeptidase are new finding for anticancer activity","volume":"134","author":"Krishnamoorthy","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106397","article-title":"Exploring the cytotoxic effect and CDK-9 inhibition potential of novel Sulfaguanidine-based Azopyrazolidine-3,5-Diones and 3,5-Diaminoazopyrazoles","volume":"133","author":"Husseiny","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0290","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41598-024-81294-1","article-title":"New thiazole derivative as a potential anticancer and topoisomerase II inhibitor","volume":"15","author":"Shosha","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118586_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152472","article-title":"Exploring the anticancer potential of novel benzimidazolium salts: synthesis, biological evaluation, DFT perspective, and docking simulation for inhibition of VEGFR2","volume":"780","author":"Kundu","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2026.118586_bb0300","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ddr.22037","article-title":"Coumarin derivatives with potential anticancer and antibacterial activity: design, synthesis, VEGFR-2 and DNA gyrase inhibition, and in silico studies","volume":"84","author":"Emam","year":"2023","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.bmc.2026.118586_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117057","article-title":"Design, synthesis and anti-tumor evaluation of novel pyrimidine and quinazoline analogues","volume":"282","author":"Lin","year":"2025","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0310","article-title":"Trifluoromethyl-substituted 3-Selenylindol and 3-Thiophenylindol induce metabolic alterations and impairment of cell cycle progression in hepatocarcinoma cells (HepG2)","volume":"128","author":"Dos Santos","year":"2025","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0315","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1080\/14756366.2022.2118735","article-title":"Design and synthesis of novel quinazolinone-based derivatives as EGFR inhibitors with antitumor activity","volume":"37","author":"Sonousi","year":"2022","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2024.112756","article-title":"Synthesis, anticancer activity, and mechanistic investigations of aryl-alkyl Diorganotin Arylformylhydrazone complexes","volume":"262","author":"Jiang","year":"2025","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.bmc.2026.118586_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/4759821","article-title":"Synthesis, anticancer assessment, and molecular docking of novel chalcone-Thienopyrimidine derivatives in HepG2 and MCF-7 cell lines","volume":"2021","author":"Safwat","year":"2021","journal-title":"Oxidative Med Cell Longev"},{"key":"10.1016\/j.bmc.2026.118586_bb0330","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/14756366.2021.1998023","article-title":"Synthesis and biological evaluation of halogenated Phenoxychalcones and their corresponding pyrazolines as cytotoxic agents in human breast Cancer","volume":"37","author":"Halim","year":"2022","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0335","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/ddr.22060","article-title":"Design, synthesis, anticancer, and antibacterial evaluation of some quinazolinone-based derivatives as DHFR inhibitors","volume":"84","author":"Osman","year":"2023","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.bmc.2026.118586_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-1407-6","article-title":"BCL-2 family isoforms in apoptosis and Cancer","volume":"10","author":"Warren","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bmc.2026.118586_bb0345","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41392-025-02176-0","article-title":"The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy","volume":"10","author":"Vogler","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmc.2026.118586_bb0350","first-page":"172","article-title":"The role of Bcl-2 in controlling the transition between autophagy and apoptosis (review)","volume":"31","author":"Palabiyik","year":"2025","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.bmc.2026.118586_bb0355","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/cells13221838","article-title":"Apoptosis: a comprehensive overview of signaling pathways, morphological changes, and physiological significance and therapeutic implications","volume":"13","author":"Mustafa","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2026.118586_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106390","article-title":"2\u2032,4\u2032-Dihydroxy-6\u2032-Methoxy-3\u2032,5\u2032-Dimethylchalcone and its amino acid-conjugated derivatives induce G0\/G1 cell cycle arrest and apoptosis via BAX\/BCL2 ratio upregulation and in silico insight in SiHa cell lines","volume":"184","author":"Utama","year":"2023","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.bmc.2026.118586_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113609","article-title":"Design, synthesis and evaluation of new Quinazolin-4-one derivatives as apoptotic enhancers and autophagy inhibitors with potent antitumor activity","volume":"222","author":"ElZahabi","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0370","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41598-024-55046-0","article-title":"New oxadiazole and pyrazoline derivatives as anti-proliferative agents targeting EGFR-TK: design, synthesis, biological evaluation and molecular docking study","volume":"14","author":"Serag","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2026.118586_bb0375","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/74651","article-title":"Mechanisms of angiogenesis and Arteriogenesis","volume":"6","author":"Carmeliet","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.bmc.2026.118586_bb0380","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/path.4904","article-title":"Hostile takeover: how tumours hijack pre-existing vascular environments to thrive","volume":"242","author":"Winkler","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.bmc.2026.118586_bb0385","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/biomedicines5020034","article-title":"The role of angiogenesis in Cancer treatment","volume":"5","author":"Rajabi","year":"2017","journal-title":"Biomedicines"},{"key":"10.1016\/j.bmc.2026.118586_bb0390","doi-asserted-by":"crossref","first-page":"23285","DOI":"10.1039\/D3RA04007K","article-title":"Identification of new theobromine-based derivatives as potent VEGFR-2 inhibitors: design, semi-synthesis, biological evaluation, and in silico studies","volume":"13","author":"Eissa","year":"2023","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2026.118586_bb0395","first-page":"1","article-title":"Synthesis, molecular docking, and investigation of enzyme inhibition activities of benzimidazole-pyrazole hybrids","volume":"67661","author":"Mehreen","year":"2025","journal-title":"J Vis Exp"},{"key":"10.1016\/j.bmc.2026.118586_bb0400","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13065-023-00965-8","article-title":"Synthesis, antimicrobial and antioxidant activity of triazole, pyrazole containing thiazole derivatives and molecular docking studies on COVID-19","volume":"17","author":"Matta","year":"2023","journal-title":"BMC Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0405","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.bmc.2026.118586_bb0410","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bmc.2026.118586_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2022.100357","article-title":"Design, synthesis, in-silico ADME prediction molecular docking and antitubercular screening of bromo-pyridyl tethered 3-Chloro 2-Azetidinone derivatives","volume":"4","author":"Kusurkar","year":"2022","journal-title":"Results Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0420","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","article-title":"Predicting drug disposition via application of BCS: transport\/absorption\/elimination interplay and development of a biopharmaceutics drug disposition classification system","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm Res"},{"key":"10.1016\/j.bmc.2026.118586_bb0425","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1526-4998(200101)57:1<3::AID-PS269>3.0.CO;2-6","article-title":"Selecting the right compounds for screening: does Lipinski\u2019s rule of 5 for pharmaceuticals apply to agrochemicals","volume":"57","author":"Tice","year":"2001","journal-title":"Pest Manag Sci"},{"key":"10.1016\/j.bmc.2026.118586_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139519","article-title":"Exploring highly selective Polymethoxy Fenamate isosteres as novel anti-prostate Cancer agents: synthesis, biological activity, molecular docking, molecular dynamics, and ADME studies","volume":"1319","author":"Tokal\u0131","year":"2025","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2026.118586_bb0435","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00706-020-02550-4","article-title":"Synthesis, in vitro antimicrobial assessment, and computational investigation of pharmacokinetic and bioactivity properties of novel Trifluoromethylated compounds using in silico ADME and toxicity prediction tools","volume":"151","author":"Ghannay","year":"2020","journal-title":"Monatsh Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0440","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. A qualitative and quantitative characterization of known drug databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J Comb Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0445","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the Oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0450","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0455","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/jm015507e","article-title":"Simple selection criteria for drug-like chemical matter","volume":"44","author":"Muegge","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0460","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2026.118586_bb0465","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00044-021-02756-z","article-title":"Design and antiproliferative and antioxidant activities of furan-based Thiosemicarbazides and 1,2,4-triazoles: their structure-activity relationship and SwissADME predictions","volume":"30","author":"Sicak","year":"2021","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmc.2026.118586_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108861","article-title":"Chalcone-inspired indole, carbazole, and phenothiazine hybrids as potent aldose reductase inhibitors with selective anticancer potential: rational design, synthesis, and multi-level characterization","volume":"164","author":"G\u00fcle\u00e7","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108689","article-title":"Fluorenyl-phthalimide hybrids as potent aldose reductase inhibitors with selective anticancer activity: rational design, synthesis, and molecular insights","volume":"163","author":"Gundogdu","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118416","article-title":"Phthalimide\u2013benzoic acid hybrids as potent aldose reductase inhibitors: synthesis, enzymatic kinetics, and in silico characterization","volume":"131","author":"Hoti","year":"2025","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0485","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1081\/DMR-120001389","article-title":"Drugs as P-glycoprotein substrates, inhibitors, and inducers","volume":"34","author":"Kim","year":"2002","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.bmc.2026.118586_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108788","article-title":"N-substituted phthalimide\u2013carboxylic acid hybrids as dual-targeted aldose reductase inhibitors: synthesis, mechanistic insights, and Cancer-relevant profiling","volume":"163","author":"Zognjani","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118586_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2025.109259","article-title":"Machine learning-guided repurposing of FDA-approved quinolones as dual cholinesterase inhibitors: a multi-level docking, molecular dynamics, DFT, and SHAP-based analysis","volume":"143","author":"T\u00fcrke\u015f","year":"2026","journal-title":"J Mol Graph Model"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626000428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626000428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:10:30Z","timestamp":1773263430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626000428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":99,"alternative-id":["S0968089626000428"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118586","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From pain relief to proliferation arrest: Synthesis and biological evaluation of novel diclofenac-tethered Schiff bases as VEGFR-2 inhibitors and apoptosis inducers, guided by in silico molecular docking and ADME profiling","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118586","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118586"}}